Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20. (Q40099210)

From Wikidata
Jump to navigation Jump to search
scientific article published on August 2007
edit
Language Label Description Also known as
English
Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20.
scientific article published on August 2007

    Statements

    Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20. (English)
    Sreeram Maddipatla
    Francisco J Hernandez-Ilizaliturri
    Myron S Czuczman

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit